Feb 28 (Reuters) - Antibe Therapeutics Inc ATE.V :
* ANTIBE THERAPEUTICS ANNOUNCES ENROLLMENT OF LAST PATIENT IN PHASE 2B DOSE-RANGING, EFFICACY STUDY OF LEAD DRUG, ATB-346
* ANTIBE THERAPEUTICS ANNOUNCES ENROLLMENT OF LAST PATIENT IN PHASE 2B DOSE-RANGING, EFFICACY STUDY OF LEAD DRUG, ATB-346
* ANTIBE THERAPEUTICS - CO ANTICIPATES RELEASE OF TOP-LINE RESULTS WITHIN SIX WEEKS